BLISS GVS PHARMA
Quarterly Results Analysis [Sep2026]
BLISS GVS PHARMA Quarterly Results
| Consolidated | Sep2026 UnAudited |
Jun2026 UnAudited |
Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹313 Cr | ₹286 Cr | ₹257 Cr | ₹218 Cr | ₹244 Cr | ₹207 Cr | ₹198 Cr | ₹210 Cr |
| Expenses | ₹233 Cr | ₹209 Cr | ₹213 Cr | ₹183 Cr | ₹201 Cr | ₹166 Cr | ₹177 Cr | ₹181 Cr |
| Operating Income | ₹81 Cr | ₹76 Cr | ₹44 Cr | ₹35 Cr | ₹43 Cr | ₹41 Cr | ₹21 Cr | ₹30 Cr |
| Other Income | ₹8 Cr | ₹10 Cr | ₹11 Cr | ₹18 Cr | ₹8 Cr | ₹35 Cr | ₹12 Cr | ₹15 Cr |
| Interest | ₹3 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹3 Cr | ₹5 Cr | ₹2 Cr | ₹1 Cr |
| Depreciation | ₹10 Cr | ₹10 Cr | ₹9 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr |
| Profit Before Tax | ₹75 Cr | ₹75 Cr | ₹45 Cr | ₹41 Cr | ₹41 Cr | ₹63 Cr | ₹23 Cr | ₹36 Cr |
| Profit After Tax | ₹53 Cr | ₹51 Cr | ₹37 Cr | ₹25 Cr | ₹29 Cr | ₹44 Cr | ₹17 Cr | ₹26 Cr |
| EPS | ₹4.91 | ₹4.72 | ₹3.36 | ₹2.20 | ₹2.58 | ₹4.08 | ₹1.47 | ₹2.26 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| BLISS GVS PHARMA | 5.1% | -8.7% | 345.9% |
| SUN PHARMACEUTICAL INDUSTRIES | 2% | -4.4% | 3.7% |
| DIVIS LABORATORIES | 7.1% | 2.5% | 46.6% |
| TORRENT PHARMACEUTICALS | 1.4% | -5.7% | 27.6% |
| CIPLA | 2% | -0.2% | -14.3% |
| DR REDDYS LABORATORIES | 3.6% | 8% | 4.2% |
| MANKIND PHARMA | 8.1% | -2.2% | 1.2% |
| LUPIN | 3% | -2.5% | 3.5% |
| ZYDUS LIFESCIENCES | 7.4% | 4.1% | 17.9% |
BLISS GVS PHARMA Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 9.73 % |
| Y-o-Y | 28.22 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Sep2026 | ₹313 Cr | 9.73 | |
| Jun2026 | ₹286 Cr | 11.12 | |
| Mar2026 | ₹257 Cr | 17.75 | |
| Dec2025 | ₹218 Cr | -10.70 | |
| Sep2025 | ₹244 Cr | 17.80 | |
| Jun2025 | ₹207 Cr | 4.79 | |
| Mar2025 | ₹198 Cr | -5.91 | |
| Dec2024 | ₹210 Cr | - | |
BLISS GVS PHARMA Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 5.48 % |
| Y-o-Y | 85.35 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Sep2026 | ₹81 Cr | 5.48 | |
| Jun2026 | ₹76 Cr | 71.92 | |
| Mar2026 | ₹44 Cr | 27.74 | |
| Dec2025 | ₹35 Cr | -19.98 | |
| Sep2025 | ₹43 Cr | 5.19 | |
| Jun2025 | ₹41 Cr | 96.01 | |
| Mar2025 | ₹21 Cr | -29.22 | |
| Dec2024 | ₹30 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -3.85 % |
| Y-o-Y | 44.58 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Sep2026 | 25.72% | -3.85 | |
| Jun2026 | 26.75% | 54.71 | |
| Mar2026 | 17.29% | 8.47 | |
| Dec2025 | 15.94% | -10.40 | |
| Sep2025 | 17.79% | -10.69 | |
| Jun2025 | 19.92% | 87.04 | |
| Mar2025 | 10.65% | -24.79 | |
| Dec2024 | 14.16% | - | |
BLISS GVS PHARMA Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 3.83 % |
| Y-o-Y | 86.59 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Sep2026 | ₹53 Cr | 3.83 | |
| Jun2026 | ₹51 Cr | 38.85 | |
| Mar2026 | ₹37 Cr | 49.32 | |
| Dec2025 | ₹25 Cr | -13.33 | |
| Sep2025 | ₹29 Cr | -35.56 | |
| Jun2025 | ₹44 Cr | 166.40 | |
| Mar2025 | ₹17 Cr | -35.46 | |
| Dec2024 | ₹26 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -5.39 % |
| Y-o-Y | 45.47 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Sep2026 | 17.02 % | -5.39 | |
| Jun2026 | 17.99 % | 24.93 | |
| Mar2026 | 14.4 % | 26.87 | |
| Dec2025 | 11.35 % | -2.99 | |
| Sep2025 | 11.7 % | -45.28 | |
| Jun2025 | 21.38 % | 154.22 | |
| Mar2025 | 8.41 % | -31.40 | |
| Dec2024 | 12.26 % | - | |
BLISS GVS PHARMA Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 4.03 % |
| Y-o-Y | 90.31 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Sep2026 | ₹4.91 | 4.03 | |
| Jun2026 | ₹4.72 | 40.48 | |
| Mar2026 | ₹3.36 | 52.73 | |
| Dec2025 | ₹2.2 | -14.73 | |
| Sep2025 | ₹2.58 | -36.76 | |
| Jun2025 | ₹4.08 | 177.55 | |
| Mar2025 | ₹1.47 | -34.96 | |
| Dec2024 | ₹2.26 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD